The Influence of Sensory Phenotype on the Risk of Developing Neuropathic Pain
- Conditions
- Peripheral Nerve InjuryPolyneuropathyNeuropathic Pain
- Interventions
- Other: QST, Questionnaires
- Registration Number
- NCT02666456
- Lead Sponsor
- University of Kiel
- Brief Summary
Cross-sectional and longitudinal analysis of the somatosensory phenotype, assessed by quantitative sensory testing (QST) and Information obtained by questionnaires to detect risk factors for neuropathic pain development and chronification in painless and chronic pain patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 1500
Inclusion Criteria
- Chronic peripheral neuropathic pain or
- Painless Patient with risk to develop neuropathic pain (post-surgery, chemotherapy-induced)
Exclusion Criteria
- Minors
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Cross-sectional cohort QST, Questionnaires Patients with chronic peripheral neuropathic pain Longitudinal cohort QST, Questionnaires Painless patients before and after potential chronic neuropathic pain-inducing interventions (chemotherapy, Operation)
- Primary Outcome Measures
Name Time Method Somatosensory phenotype detected by quantitative sensory testing (QST) Single assessment at baseline (cross-sectional study). Report of complete cohort data at study completion The somatosensory phenotype will be assessed by quantitative sensory testing (QST) once at baseline
Change of neuropathic pain: Development and chronification of neuropathic pain detected by DN4 questionnaire Assessment of change of neuropathic pain from baseline and 6 months after study enrollment (longitudinal study). Report of complete cohort data at study completion. Assessment with DN4 pain questionnaire
- Secondary Outcome Measures
Name Time Method